feed,title,long_url,short_url
Benzinga,"Why Hepion Pharma, Sesen Bio And More Are Moving Today",https://www.benzinga.com/news/21/02/19680352/why-hepion-pharma-sesen-bio-and-more-are-moving-today,https://j.mp/3apR6aB
Benzinga,Jennifer Cardella joins Digital Prism Advisors as Chief Product and Delivery Officer,https://www.benzinga.com/pressreleases/21/02/n19680517/jennifer-cardella-joins-digital-prism-advisors-as-chief-product-and-delivery-officer,https://j.mp/3rSSybg
Benzinga,The Greater Women's Business Council Announces New Board Chair and 2021 Board Members,https://www.benzinga.com/pressreleases/21/02/n19680487/the-greater-womens-business-council-announces-new-board-chair-and-2021-board-members,https://j.mp/3apWavG
Benzinga,Carnival Corporation & plc Announces Closing of $3.5 Billion 5.75% Senior Unsecured Notes due 2027,https://www.benzinga.com/pressreleases/21/02/n19680484/carnival-corporation-plc-announces-closing-of-3-5-billion-5-75-senior-unsecured-notes-due-2027,https://j.mp/37kwxu4
Benzinga,Global Nutraceutical Ingredients Market Report 2020-2025: COVID-19 and Its Impact on Target Therapy Consumer Preferences Create Future Growth Potential,https://www.benzinga.com/pressreleases/21/02/n19680483/global-nutraceutical-ingredients-market-report-2020-2025-covid-19-and-its-impact-on-target-therapy,https://j.mp/2Zmeorr
Benzinga,iBiopsy®: Median Technologies Continues Its Strong Positioning in Early-Stage Diagnosis with a New iBiopsy® Clinical Development Plan on Lung Cancer Screening (LCS),https://www.benzinga.com/pressreleases/21/02/b19680482/ibiopsy-median-technologies-continues-its-strong-positioning-in-early-stage-diagnosis-with-a-new-i,https://j.mp/2NuziC3
